Current studies with PTK787, an oral inhibitor of vascular endothelial growth factor in colorectal cancer.

Authors	Jennifer Klem
Journal	Clinical colorectal cancer (Clin Colorectal Cancer) Vol. 3 Issue 3 Pg. 147-9 (Nov 2003) ISSN: 1533-0028 [Print] United States
PMID	14706172 (Publication Type: Journal Article, Review)
Chemical References	Angiogenesis Inhibitors Phthalazines Pyridines vatalanib
Topics	Administration, Oral Angiogenesis Inhibitors (administration & dosage, therapeutic use) Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Colorectal Neoplasms (drug therapy) Humans Phthalazines (administration & dosage, therapeutic use) Pyridines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!